2016
DOI: 10.1111/pim.12339
|View full text |Cite
|
Sign up to set email alerts
|

Strategies for new and improved vaccines against ticks and tick‐borne diseases

Abstract: SUMMARYTicks infest a variety of animal species and transmit pathogens causing disease in both humans and animals worldwide. Tick-host-pathogen interactions have evolved through dynamic processes that accommodated the genetic traits of the hosts, pathogens transmitted and the vector tick species that mediate their development and survival. New approaches for tick control are dependent on defining molecular interactions between hosts, ticks and pathogens to allow for discovery of key molecules that could be tes… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
102
0
1

Year Published

2017
2017
2021
2021

Publication Types

Select...
4
3
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 110 publications
(104 citation statements)
references
References 175 publications
(220 reference statements)
1
102
0
1
Order By: Relevance
“…More recently, new technologies have made tractable approaches based on a deeper understanding of complex tick-pathogen-host interactions (de la Fuente et al, 2016a; Kuleš et al, 2016). For example, SILK (a salivary gland-expressed flagelliform protein of unknown function) and TROSPA (tick receptor for OspA localized in the gut) facilitate transmission of cattle tick-borne pathogens, Anaplasma marginale and Babesia bigemina , respectively.…”
Section: Vaccinesmentioning
confidence: 99%
“…More recently, new technologies have made tractable approaches based on a deeper understanding of complex tick-pathogen-host interactions (de la Fuente et al, 2016a; Kuleš et al, 2016). For example, SILK (a salivary gland-expressed flagelliform protein of unknown function) and TROSPA (tick receptor for OspA localized in the gut) facilitate transmission of cattle tick-borne pathogens, Anaplasma marginale and Babesia bigemina , respectively.…”
Section: Vaccinesmentioning
confidence: 99%
“…Results using next generation sequencing technologies have advanced our understanding of the mechanisms by which A. phagocytophilum infection affects gene expression, protein content and microbiota in the vertebrate host and tick vector (Ge and Rikihisa, 2006; Sukumaran et al, 2006; de la Fuente et al, 2010, 2016a,b,c,d, 2017, Neelakanta et al, 2010; Rikihisa, 2011; Severo et al, 2012; Ayllón et al, 2013, 2015; Hajdušek et al, 2013; Villar et al, 2015a; Cabezas-Cruz et al, 2016, 2017; Gulia-Nuss et al, 2016; Abraham et al, 2017; Mansfield et al, 2017). However, less information is available on the bacterial molecules involved in pathogen infection and multiplication (Ge and Rikihisa, 2007; Huang et al, 2010; Lin et al, 2011; Troese et al, 2011; Mastronunzio et al, 2012; Oliva Chávez et al, 2015; Seidman et al, 2015; Villar et al, 2015b; Truchan et al, 2016).…”
Section: Introductionmentioning
confidence: 99%
“…This challenge could have been the reason for failure of the recombinant AQP1 protein as vaccine against I. ricinus [15]. Future AQP1-anti-tick vaccines therefore should at least be based on reverse vaccinology methods focusing on unique tick peptide motifs that might constitute vaccine development pipeline [47]. Peptide based vaccines use specific peptide fragments that induce high specific immune response thereby increase vaccine efficacy and reduce potential adverse effects caused by whole protein vaccination [48].…”
Section: Discussionmentioning
confidence: 99%